Overview

Misoprostol for NASH

Status:
Completed
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The aim of this randomised control trial is to evaluate the effect of Misoprostol in treating patients with NASH.
Phase:
Phase 2
Details
Lead Sponsor:
Ziauddin University
Collaborator:
Nabiqasim Industries (Pvt) Ltd
Treatments:
Misoprostol